The overall survival and SV2B high/low expression in GBM patients were the only association that showed significant difference statistically (Logrank P=0.015; HR (high) = 1.6; P(HR) = 0.016; n(high) = 81; n(low) = 81; Figure 4). This evidence concerns the gene SV2B and glioblastoma.